JORI REIGLE: Open Payments
NPI 1598367476 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 12 payments from 8 companies in 2025. Trend: 2023 $662 · 2024 $419 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $125 |
| Alkermes, Inc. | 5 | $117 |
| Madrigal Pharmaceuticals | 1 | $107 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lundbeck LLC | 1 | $14 |
Products named: JOURNAVX, ARISTADA, REZDIFFRA, INGREZZA, MAVYRET, Auvelity, CAPLYTA, REXULTI.
Industry payments across MI — which companies pay providers there.
